The Pharma Legal Handbook: United Arab Emirates

The United Arab Emirates is the most commercially advanced pharmaceutical market in the Middle East and a major hub for pharmaceutical distribution across the GCC and wider region. The regulatory environment is divided between the federal Ministry of Health and Prevention (MOHAP), the Dubai Health Authority (DHA), and the Department of Health Abu Dhabi (DOH), creating a multi-authority structure.

The UAE's healthcare sector has expanded significantly under the national health insurance mandate, creating a substantial private market alongside the public healthcare system. The country's free zones, including the Dubai Healthcare City, offer specific regulatory and commercial arrangements that are relevant for companies considering the UAE as a regional base.

The Pharma Legal Handbook: United Arab Emirates provides comprehensive guidance on pharmaceutical regulation in the UAE, covering MOHAP, DHA and DOH product registration requirements, pricing frameworks, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, and intellectual property protection.